We are live on ! Find out more
KAS

Kestra Advisory Services Portfolio holdings

AUM $31B
1-Year Est. Return 28.39%
This Fund
S&P 500
This Quarter Est. Return
-2.99%
1 Year Est. Return
+28.39%
3 Year Est. Return
+85.12%
5 Year Est. Return
+94.26%
10 Year Est. Return
AUM
$10.2B
AUM Growth
+$182M
Cap. Flow
+$539M
Cap. Flow %
5.3%
Top 10 Hldgs %
18.12%
Holding
2,267
New
166
Increased
1,181
Reduced
705
Closed
162

Sector Composition

Rank Sector Weight
1 Technology 10.41%
2 Industrials 6.63%
3 Financials 5.53%
4 Healthcare 4.58%
5 Consumer Discretionary 4.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSM icon
2076
Fortuna Silver Mines
FSM
$2.55B
$27.9K ﹤0.01%
10,275
+250
+2% +$784
DNA icon
2077
Ginkgo Bioworks
DNA
$528M
$26.8K ﹤0.01%
370
+88
+31% +$7.04K
VERI icon
2078
Veritone
VERI
$101M
$26.6K ﹤0.01%
+10,321
New +$34.3K
USEA icon
2079
United Maritime
USEA
$25.1M
$25.3K ﹤0.01%
10,552
+285
+3% +$720
BFLY icon
2080
Butterfly Network
BFLY
$1.89B
$25K ﹤0.01%
21,216
-426
-2% -$825
SNCR
2081
DELISTED
Synchronoss Technologies
SNCR
$24K ﹤0.01%
2,778
EMX
2082
DELISTED
EMX Royalty
EMX
$19.6K ﹤0.01%
11,000
PLX icon
2083
Protalix BioTherapeutics
PLX
$191M
$19.1K ﹤0.01%
11,500
SENS icon
2084
Senseonics Holdings Inc
SENS
$263M
$19K ﹤0.01%
1,577
-50
-3% -$690
WKHS icon
2085
Workhorse Group
WKHS
$33.2M
$18.9K ﹤0.01%
15
+2
+15% +$5.14K
BKSY icon
2086
BlackSky Technology
BKSY
$943M
$18.3K ﹤0.01%
1,960
CENN icon
2087
Cenntro
CENN
$7.89M
$18.3K ﹤0.01%
125
NBSE
2088
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$15.6K ﹤0.01%
17,976
-7,507
-29% -$9.22K
GRTX
2089
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$15K ﹤0.01%
+85,750
New +$107K
PLBY icon
2090
Playboy Inc
PLBY
$128M
$13.9K ﹤0.01%
17,387
+1,700
+11% +$2.44K
INSG icon
2091
Inseego
INSG
$114M
$13.8K ﹤0.01%
3,284
SABS icon
2092
SAB Biotherapeutics
SABS
$273M
$13.2K ﹤0.01%
2,100
PRQR icon
2093
ProQR Therapeutics
PRQR
$243M
$13K ﹤0.01%
10,000
FBIO icon
2094
Fortress Biotech
FBIO
$104M
$12.9K ﹤0.01%
2,960
-3,670
-55% -$25.2K
VFF icon
2095
Village Farms International
VFF
$234M
$11.7K ﹤0.01%
14,643
-1,015
-6% -$779
KYNB
2096
Kyntra Bio
KYNB
$27.2M
$10.9K ﹤0.01%
506
HTCR icon
2097
HeartCore Enterprises
HTCR
$3.3M
$10.4K ﹤0.01%
525
VXRT
2098
DELISTED
Vaxart
VXRT
$9.74K ﹤0.01%
12,919
-1
-0% -$1
RBOT
2099
DELISTED
Vicarious Surgical
RBOT
$9.04K ﹤0.01%
510
-14
-3% -$510
ICU icon
2100
SeaStar Medical
ICU
$12.5M
$7.64K ﹤0.01%
116
-12
-9% -$1.08K

Similar funds

Kestra Advisory Services's Q3 2023 Portfolio in Review

As of Q3 2023, Kestra Advisory Services held 2,267 positions worth $10.2B, up 1.8% from $9.99B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Kestra Advisory Services deployed $539M of net new capital in Q3 2023, opening 166 new positions and adding to 1,181 existing holdings. Its largest new stake was First Trust India Nifty 50 Equal Weight ETF: 140,453 shares worth $6.83M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was First Trust Enhanced Short Maturity ETF, an estimated $14.2M trimmed.

  • Kestra Advisory Services's largest Q3 2023 buy was First Trust India Nifty 50 Equal Weight ETF: 140,453 shares worth $6.83M.
  • Kestra Advisory Services added most to WisdomTree Floating Rate Treasury Fund in Q3 2023, an estimated $23.9M increase.
  • Kestra Advisory Services's biggest Q3 2023 reduction was First Trust Enhanced Short Maturity ETF, cutting an estimated $14.2M.
  • Kestra Advisory Services fully exited FS Credit Opportunities Corp in Q3 2023, selling an estimated $4.47M.
  • Kestra Advisory Services's ten largest holdings make up 18% of its $10.2B portfolio in Q3 2023.
  • Kestra Advisory Services opened 166 new positions and closed 162 in Q3 2023.
  • Kestra Advisory Services's portfolio value rose 1.8% quarter-over-quarter to $10.2B.

Based on Kestra Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.